ProfileGDS4718 / 227776_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 94% 85% 95% 95% 92% 86% 95% 94% 95% 95% 95% 93% 91% 90% 93% 94% 89% 87% 69% 95% 96% 93% 95% 96% 88% 96% 89% 96% 90% 89% 83% 95% 95% 83% 92% 90% 93% 95% 83% 95% 89% 90% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.720996
GSM549102patient 115, normal, homogenized [OPG study]9.9176494
GSM549104patient 119, normal, homogenized [OPG study]8.5866685
GSM549108patient 138, normal, homogenized [OPG study]10.335495
GSM549119patient 077, normal, homogenized [OPG study]10.471895
GSM549133patient 032, cancer, homogenized [OPG study]9.5530692
GSM549139patient 042, cancer, homogenized [OPG study]8.6343886
GSM549099patient 107, normal, homogenized [OPG study]10.133195
GSM549109patient 139, normal, homogenized [OPG study]10.0294
GSM549110patient 046, normal, homogenized [OPG study]10.420195
GSM549114patient 063, normal, homogenized [OPG study]10.469495
GSM549122patient 082, normal, homogenized [OPG study]10.357295
GSM549134patient 033, cancer, homogenized [OPG study]9.744793
GSM549136patient 036, cancer, homogenized [OPG study]9.4893891
GSM549140patient 044, cancer, homogenized [OPG study]9.1638390
GSM549111patient 047, normal, homogenized [OPG study]9.9498293
GSM549113patient 057, normal, homogenized [OPG study]10.21594
GSM549132patient 031, cancer, homogenized [OPG study]9.0714889
GSM549137patient 038, cancer, homogenized [OPG study]8.7510487
GSM549142patient 047, cancer, homogenized [OPG study]6.7760369
GSM549100patient 110, normal, homogenized [OPG study]10.389795
GSM549107patient 135, normal, homogenized [OPG study]10.557496
GSM549115patient 068, normal, homogenized [OPG study]10.003193
GSM549116patient 072, normal, homogenized [OPG study]10.464795
GSM549120patient 078, normal, homogenized [OPG study]10.641396
GSM549131patient 030, cancer, homogenized [OPG study]9.0181788
GSM549118patient 074, normal, homogenized [OPG study]10.612796
GSM549129patient 027, cancer, homogenized [OPG study]8.9028389
GSM549123patient 088, normal, homogenized [OPG study]10.726896
GSM549124patient 006, cancer, homogenized [OPG study]9.1293690
GSM549126patient 015, cancer, homogenized [OPG study]9.0445689
GSM549128patient 025, cancer, homogenized [OPG study]8.3247583
GSM549103patient 117, normal, homogenized [OPG study]10.309795
GSM549117patient 073, normal, homogenized [OPG study]10.573995
GSM549138patient 041, cancer, homogenized [OPG study]8.2735683
GSM549141patient 045, cancer, homogenized [OPG study]9.627692
GSM549130patient 028, cancer, homogenized [OPG study]9.0167490
GSM549101patient 111, normal, homogenized [OPG study]9.6827493
GSM549105patient 128, normal, homogenized [OPG study]10.295995
GSM549106patient 134, normal, homogenized [OPG study]8.3893683
GSM549112patient 048, normal, homogenized [OPG study]10.523295
GSM549125patient 011, cancer, homogenized [OPG study]8.9127189
GSM549127patient 024, cancer, homogenized [OPG study]9.1660790
GSM549135patient 035, cancer, homogenized [OPG study]8.5330785